CompletedPhase 3NCT01570504
Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
Studying Strongyloidiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centro per le Malattie Tropicali
- Principal Investigator
- Zeno Bisoffi, MD, PhDCentre for Tropical Diseases, Negrar (Verona), Italy
- Intervention
- Ivermectin(drug)
- Enrollment
- 312 target
- Eligibility
- 6 years · All sexes
- Timeline
- 2013 – 2018
Study locations (9)
- Centro per le Malattie Tropicali, Ospedale Sacro Cuore, Negrar, Verona, Italy
- Clinica di Malattie Infettive e Tropicali, Brescia, Italy
- UFDID, Azienda Ospedaliero-universitaria Careggi, Florence, Italy
- Unità di Malattie Infettive, Anna Meyer Children's Universisty Hospital, Florence, Italy
- Unidad de Medicina, Hospital de Poniente-El Ejido, El Ejido, Almeria, Spain
- FCRB, Hospital Clinic de Barcelona, Barcelona, Spain
- Unitat Medicina Tropical i Salut Internacional Drassanes, Barcelona, Spain
- Addenbrookes Hospital, Cambridge University Hospital, Cambridge, United Kingdom
- UCLH, London, United Kingdom
Collaborators
European Commission
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01570504 on ClinicalTrials.gov